Murphy-Chutorian Douglas

CEO, interim CFO and Director, DirectorSemler Scientific, Inc. (SMLR) · full profile →Form 4 · filed Nov 18, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.4M
Net Open-Market Flow
-$1.4M
Transactions
6
5 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 17, 2025Gift(G)55K$0241K
Nov 17, 2025Gift(G)55K$00
Nov 17, 2025Option exercise(M)125K$2.23$279K125K
Nov 17, 2025Sell(S)58K$20.09$1.2M67K
Nov 17, 2025Sell(S)13K$20.73$264K55K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 17, 2025Option exercise(M)125K$00

Transaction Codes

G
Gift
M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-113647) within minutes of acceptance. Every field above traces to the original document. Verify it directly: